Furthermore, they found precursor T cells responding to PLAC1 peptide epitopes in the peripheral blood of HNSCC patients, suggesting a potential role of PLAC1 as a target antigen for immunotherapy, which requires further exploration [116]. Here, PLAC1 is linked to head and neck squamous cell carcinoma.